Tubigon, Jerry P.
HRN: 22-44-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/17/2024
12/24/2024
IV
4.5grams
Every 8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes